# PFIZER INC

Summary updated: 2026-03-19T00:37:43.385059Z
Canonical: https://finbar.com/research/companies/pfizer

## Overview

Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, markets, sells and distributes biopharmaceutical products worldwide. Its commercial operations are organized around Biopharma, its innovative science-based medicines and vaccines business, alongside PC1, a contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients, and Pfizer Ignite, which provides strategic guidance and end-to-end R&D services to selected biotech companies. Pfizer’s portfolio is defined by therapeutic areas including oncology, internal medicine, vaccines, inflammation and immunology, and rare disease. The company states its purpose as “Breakthroughs that change patients’ lives.” [1](https://app.finbar.com/go?id=P-61ebacb40e80479d8e7a65aa0d0a89f1)[2](https://app.finbar.com/go?id=P-6ab72ff2f5a344aa96334c468dde3e4c)[3](https://app.finbar.com/go?id=P-5b560eda98514453a4908546ad2bde9e)[4](https://app.finbar.com/go?id=P-7a28a0aa99b945bfad572496e21d67ce)

Founded in 1849, Pfizer is headquartered in New York City and supplies medicines and vaccines to approximately 200 countries and territories. The company had approximately 81,000 employees worldwide as of December 31, 2024, and reported 2024 revenue of about $63.6 billion. Its business is globally diversified, with international operations contributing 39% of total revenue in 2024. [5](https://www.pfizer.com/about/history)[6](https://app.finbar.com/go?id=P-0048d32bf1c042b5bdd574e983a9326c)[7](https://app.finbar.com/go?id=P-adae110d32d74cacb401ed81d286242f)[8](https://app.finbar.com/go?id=P-6ca303add65a4819833381ae65bd6347)[9](https://app.finbar.com/go?id=P-a635641793d040cfb4966428ba35a285)[10](https://app.finbar.com/go?id=P-688324bcfa3e4d3c8652abe6df3f7162)
[1](https://app.finbar.com/go?id=P-61ebacb40e80479d8e7a65aa0d0a89f1)[2](https://app.finbar.com/go?id=P-6ab72ff2f5a344aa96334c468dde3e4c)[3](https://app.finbar.com/go?id=P-5b560eda98514453a4908546ad2bde9e)[4](https://app.finbar.com/go?id=P-7a28a0aa99b945bfad572496e21d67ce)[6](https://app.finbar.com/go?id=P-0048d32bf1c042b5bdd574e983a9326c)[7](https://app.finbar.com/go?id=P-adae110d32d74cacb401ed81d286242f)[8](https://app.finbar.com/go?id=P-6ca303add65a4819833381ae65bd6347)[9](https://app.finbar.com/go?id=P-a635641793d040cfb4966428ba35a285)[10](https://app.finbar.com/go?id=P-688324bcfa3e4d3c8652abe6df3f7162)[5](https://www.pfizer.com/about/history)

## Products & services

Pfizer’s marketed products span internal medicine, migraine, vaccines, COVID-19 treatment and testing, inflammation and immunology, rare disease, hospital medicines, and oncology. Named products include Eliquis, the Premarin family and BMP2 in internal medicine; Nurtec ODT/Vydura and Zavzpret for migraine; Comirnaty, the Prevnar family, Abrysvo, FSME-IMMUN/TicoVac, Nimenrix and Trumenba in vaccines; Paxlovid and Lucira by Pfizer in COVID-19 treatment and detection; Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo and Velsipity in inflammation and immunology; the Vyndaqel family, Genotropin, BeneFIX, Oxbryta, Somavert and Ngenla in rare disease; Sulperazon, Zavicefta, Zithromax, Medrol and Panzyga in hospital medicines; and Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak in oncology [11](https://app.finbar.com/go?id=P-9dde80b9e1614abd92bd03eb95bc5cfc)[12](https://app.finbar.com/go?id=P-8e6b67e9976f431f947979c3e29b3d90)[13](https://app.finbar.com/go?id=P-361790b816404cea9011bd0f33d8c38b)[14](https://app.finbar.com/go?id=P-72981c3bcee54ff1b70c379afe50ecf5)[15](https://app.finbar.com/go?id=P-0c10315050c4459f9704e613598d0a08)[16](https://app.finbar.com/go?id=P-dc0a49a2ef40469ca4e85f9e4ddba4da)[17](https://app.finbar.com/go?id=P-c97332d1ba164fcaa0e572a1d2945949)[18](https://app.finbar.com/go?id=P-4e94ad12cfa948c6a95fcb1b6cb4cc48)[19](https://app.finbar.com/go?id=P-6110151472f0474fa803215f70c1c7ef).

Several major products are described with specific technical characteristics. Comirnaty is an mRNA-based coronavirus vaccine; Eliquis (apixaban) is a novel oral anticoagulant positioned as an alternative to warfarin; Xtandi (enzalutamide) is an androgen receptor inhibitor that blocks multiple steps in the androgen receptor signaling pathway; Ibrance (palbociclib) is used in HR-positive/HER2-negative metastatic breast cancer; and Paxlovid contains the antiviral nirmatrelvir [20](https://app.finbar.com/go?id=P-d0c8cbf2d95149249f5f94997c60502c)[21](https://app.finbar.com/go?id=P-ee854c03dca545fdb35e15329d71acf9)[22](https://app.finbar.com/go?id=P-ae61786f722940adb785b57ac5de0341)[23](https://app.finbar.com/go?id=P-963192f867fa43c69a12057805b68fae)[24](https://app.finbar.com/go?id=P-93c7b91de55d48b5bfbb1f8f5c595bca). Pfizer describes its hospital portfolio as sterile injectable and immunoglobulin medicines, while its oncology portfolio includes antibody-drug conjugates, small molecules, bispecifics, other immunotherapies, and oncology biosimilars [25](https://app.finbar.com/go?id=T-bb17e7d1195d4692aeef32dad13c8697).

Based on disclosed 2024 product sales relative to total biopharma revenue of $62.4 billion, Eliquis represented about 11.8% of biopharma revenue, the Prevnar family about 10.3%, Paxlovid about 9.2%, the Vyndaqel family about 8.7%, Comirnaty about 8.6%, Ibrance about 7.0%, and Xtandi about 3.3% [26](https://app.finbar.com/go?id=T-bcf7faeb77c249839911b0b6eca479b1)[27](https://app.finbar.com/go?id=T-20d86cca8ed143e99b385e251c39f042)[28](https://app.finbar.com/go?id=T-8b8c9ffce5844f53a901fc75f239e175). Beyond marketed medicines, Pfizer also states that it provides end-to-end R&D services to select innovative biotech companies, and it reports Pfizer CentreOne as a separate business innovation line [29](https://app.finbar.com/go?id=P-662b594968f24767804ef803cefee1e8)[30](https://app.finbar.com/go?id=P-7c1de3b5bdee4b50906e0217b04a3f48)[31](https://app.finbar.com/go?id=T-64ef49bdce7b46ac97148b18853d38ec).
[11](https://app.finbar.com/go?id=P-9dde80b9e1614abd92bd03eb95bc5cfc)[12](https://app.finbar.com/go?id=P-8e6b67e9976f431f947979c3e29b3d90)[13](https://app.finbar.com/go?id=P-361790b816404cea9011bd0f33d8c38b)[14](https://app.finbar.com/go?id=P-72981c3bcee54ff1b70c379afe50ecf5)[15](https://app.finbar.com/go?id=P-0c10315050c4459f9704e613598d0a08)[16](https://app.finbar.com/go?id=P-dc0a49a2ef40469ca4e85f9e4ddba4da)[17](https://app.finbar.com/go?id=P-c97332d1ba164fcaa0e572a1d2945949)[18](https://app.finbar.com/go?id=P-4e94ad12cfa948c6a95fcb1b6cb4cc48)[19](https://app.finbar.com/go?id=P-6110151472f0474fa803215f70c1c7ef)[20](https://app.finbar.com/go?id=P-d0c8cbf2d95149249f5f94997c60502c)[21](https://app.finbar.com/go?id=P-ee854c03dca545fdb35e15329d71acf9)[22](https://app.finbar.com/go?id=P-ae61786f722940adb785b57ac5de0341)[23](https://app.finbar.com/go?id=P-963192f867fa43c69a12057805b68fae)[24](https://app.finbar.com/go?id=P-93c7b91de55d48b5bfbb1f8f5c595bca)[25](https://app.finbar.com/go?id=T-bb17e7d1195d4692aeef32dad13c8697)[26](https://app.finbar.com/go?id=T-bcf7faeb77c249839911b0b6eca479b1)[27](https://app.finbar.com/go?id=T-20d86cca8ed143e99b385e251c39f042)[28](https://app.finbar.com/go?id=T-8b8c9ffce5844f53a901fc75f239e175)[29](https://app.finbar.com/go?id=P-662b594968f24767804ef803cefee1e8)[30](https://app.finbar.com/go?id=P-7c1de3b5bdee4b50906e0217b04a3f48)[31](https://app.finbar.com/go?id=T-64ef49bdce7b46ac97148b18853d38ec)

## Geographic presence

Pfizer’s geographic revenue base is weighted toward the United States, which generated $38.7 billion of 2024 revenue, or about 60.8% of the total, while international markets generated $24.9 billion, or about 39.2%. Within international revenue, developed markets accounted for $16.1 billion, or about 25.2% of total revenue, and emerging markets accounted for $8.9 billion, or about 13.9%. Pfizer also states that 19% of total 2024 revenue came from Europe and 13% from China, Japan and the rest of the Asia Pacific region. [32](https://app.finbar.com/go?id=T-9784d5e1fb524ab39821c261a59a5364)[10](https://app.finbar.com/go?id=P-688324bcfa3e4d3c8652abe6df3f7162)

Pfizer’s global headquarters are in New York City, with principal executive offices at 66 Hudson Boulevard East, New York, New York 10001-2192. The company reported 251 owned and leased properties worldwide totaling about 37 million square feet. Its manufacturing network is broadly international: Pfizer Global Supply had responsibility for 37 plants worldwide, including facilities in Belgium, Germany, India, Ireland, Italy, Japan, Singapore and the United States. Outside the U.S., the company leases R&D laboratories in the U.K., India and Belgium. [6](https://app.finbar.com/go?id=P-0048d32bf1c042b5bdd574e983a9326c)[33](https://app.finbar.com/go?id=P-a88c9b4598bb4230abce1161433e96ab)[34](https://app.finbar.com/go?id=P-a22652019972488c81774a784d90d7be)[35](https://app.finbar.com/go?id=P-7d6bd27ef6d249a0aa0d6275d5fc3430)

Pfizer employed approximately 81,000 people worldwide as of December 31, 2024, although the company does not provide a regional breakdown of employees in the cited disclosure. [8](https://app.finbar.com/go?id=P-6ca303add65a4819833381ae65bd6347)
[32](https://app.finbar.com/go?id=T-9784d5e1fb524ab39821c261a59a5364)[10](https://app.finbar.com/go?id=P-688324bcfa3e4d3c8652abe6df3f7162)[6](https://app.finbar.com/go?id=P-0048d32bf1c042b5bdd574e983a9326c)[33](https://app.finbar.com/go?id=P-a88c9b4598bb4230abce1161433e96ab)[34](https://app.finbar.com/go?id=P-a22652019972488c81774a784d90d7be)[35](https://app.finbar.com/go?id=P-7d6bd27ef6d249a0aa0d6275d5fc3430)[8](https://app.finbar.com/go?id=P-6ca303add65a4819833381ae65bd6347)

## Business segments

Pfizer said in 2024 that it managed operations through three operating segments—Biopharma, PC1 and Pfizer Ignite—but only Biopharma met the criteria to be a reportable segment. Biopharma is the core innovative biopharmaceutical business; PC1 is the company’s contract development and manufacturing organization and a supplier of specialty active pharmaceutical ingredients; and Pfizer Ignite provides strategic guidance and end-to-end R&D services to selected biotech companies aligned with Pfizer’s R&D focus areas. Based on 2024 revenue, Biopharma contributed about 98% of total company revenue, while PC1 contributed about 1.8% and Pfizer Ignite about 0.1%; externally, Pfizer also groups PC1 and Pfizer Ignite together as “other business activities,” at about 1.9% of total revenue. [1](https://app.finbar.com/go?id=P-61ebacb40e80479d8e7a65aa0d0a89f1)[36](https://app.finbar.com/go?id=T-4a848363ec8047a98188a4e22390323c)[37](https://app.finbar.com/go?id=P-ae83f37b6348471eaa9a6e835e3ba9e0)

Within Biopharma, Pfizer also presents a commercial portfolio view rather than additional reportable segments. In 2024, Biopharma’s commercial structure comprised the Pfizer Oncology Division, the Pfizer U.S. Commercial Division and the Pfizer International Commercial Division, and its products were organized into Primary Care, Specialty Care and Oncology portfolios. Primary Care covers internal medicine, migraine, vaccines and COVID-19 treatment; Specialty Care covers inflammation and immunology, rare disease and hospital; and Oncology covers oncology products and biosimilars. Using 2024 revenue, these portfolio groupings represented about 48% of Biopharma revenue for Primary Care, 27% for Specialty Care and 25% for Oncology, equivalent to roughly 47%, 26% and 25% of Pfizer’s total revenue, respectively. These are management portfolio groupings within Biopharma, not separate reportable segments. [38](https://app.finbar.com/go?id=P-c648e0845f984486bfbb3a8b038cf8b3)[25](https://app.finbar.com/go?id=T-bb17e7d1195d4692aeef32dad13c8697)[39](https://app.finbar.com/go?id=T-f9e7cc0d7583483fb0e95f4b7323b63e)[1](https://app.finbar.com/go?id=P-61ebacb40e80479d8e7a65aa0d0a89f1)
[1](https://app.finbar.com/go?id=P-61ebacb40e80479d8e7a65aa0d0a89f1)[36](https://app.finbar.com/go?id=T-4a848363ec8047a98188a4e22390323c)[37](https://app.finbar.com/go?id=P-ae83f37b6348471eaa9a6e835e3ba9e0)[38](https://app.finbar.com/go?id=P-c648e0845f984486bfbb3a8b038cf8b3)[25](https://app.finbar.com/go?id=T-bb17e7d1195d4692aeef32dad13c8697)[39](https://app.finbar.com/go?id=T-f9e7cc0d7583483fb0e95f4b7323b63e)

## Company history

Pfizer was founded in 1849 in Brooklyn, New York, by cousins Charles Pfizer and Charles Erhart. In the 1930s, it became a leading producer of vitamin C and citric acid, and in 1941 it mass-produced penicillin at a scale that had not previously been achieved. Pfizer introduced the antibiotic Terramycin in 1950, and Viagra later received its initial U.S. approval in 1998. [5](https://www.pfizer.com/about/history)[40](https://cdn.pfizer.com/pfizercom/Pfizer_Legacy_of_Manufacturing_Excellence_04042024.pdf)[41](https://labeling.pfizer.com/ShowLabeling.aspx?id=652)

From 2000 onward, Pfizer was reshaped by a series of major transactions, acquiring Warner-Lambert in 2000, Pharmacia in 2003, and Wyeth in 2009. It later completed the full disposition of its animal health business, Zoetis, in 2013, acquired Hospira in 2015, and in 2020 completed the separation of Upjohn and its combination with Mylan to form Viatris. [42](https://app.finbar.com/go?id=P-b34fdae5806e4361a94abad7b64b1674)[43](https://app.finbar.com/go?id=P-ac83057bbe0e456ab1e556d16d6b12f5)[44](https://app.finbar.com/go?id=P-6aa7094537d04714b85e7be40264aafa)[45](https://app.finbar.com/go?id=P-55b41cf14a2745aeb03ea125fd78f107)[46](https://app.finbar.com/go?id=P-21ceb5df957948c4a1af4871c4dd520b)[47](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-transaction-combine-its-upjohn-business)
[42](https://app.finbar.com/go?id=P-b34fdae5806e4361a94abad7b64b1674)[43](https://app.finbar.com/go?id=P-ac83057bbe0e456ab1e556d16d6b12f5)[44](https://app.finbar.com/go?id=P-6aa7094537d04714b85e7be40264aafa)[45](https://app.finbar.com/go?id=P-55b41cf14a2745aeb03ea125fd78f107)[46](https://app.finbar.com/go?id=P-21ceb5df957948c4a1af4871c4dd520b)[5](https://www.pfizer.com/about/history)[40](https://cdn.pfizer.com/pfizercom/Pfizer_Legacy_of_Manufacturing_Excellence_04042024.pdf)[41](https://labeling.pfizer.com/ShowLabeling.aspx?id=652)[47](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-transaction-combine-its-upjohn-business)

## Sources

1. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-61ebacb40e80479d8e7a65aa0d0a89f1)
2. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-6ab72ff2f5a344aa96334c468dde3e4c)
3. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-5b560eda98514453a4908546ad2bde9e)
4. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-7a28a0aa99b945bfad572496e21d67ce)
5. [www.pfizer.com](https://www.pfizer.com/about/history)
6. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-0048d32bf1c042b5bdd574e983a9326c)
7. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-adae110d32d74cacb401ed81d286242f)
8. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-6ca303add65a4819833381ae65bd6347)
9. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-a635641793d040cfb4966428ba35a285)
10. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-688324bcfa3e4d3c8652abe6df3f7162)
11. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-9dde80b9e1614abd92bd03eb95bc5cfc)
12. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-8e6b67e9976f431f947979c3e29b3d90)
13. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-361790b816404cea9011bd0f33d8c38b)
14. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-72981c3bcee54ff1b70c379afe50ecf5)
15. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-0c10315050c4459f9704e613598d0a08)
16. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-dc0a49a2ef40469ca4e85f9e4ddba4da)
17. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-c97332d1ba164fcaa0e572a1d2945949)
18. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-4e94ad12cfa948c6a95fcb1b6cb4cc48)
19. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-6110151472f0474fa803215f70c1c7ef)
20. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-d0c8cbf2d95149249f5f94997c60502c)
21. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-ee854c03dca545fdb35e15329d71acf9)
22. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-ae61786f722940adb785b57ac5de0341)
23. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-963192f867fa43c69a12057805b68fae)
24. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-93c7b91de55d48b5bfbb1f8f5c595bca)
25. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-bb17e7d1195d4692aeef32dad13c8697)
26. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-bcf7faeb77c249839911b0b6eca479b1)
27. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-20d86cca8ed143e99b385e251c39f042)
28. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-8b8c9ffce5844f53a901fc75f239e175)
29. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-662b594968f24767804ef803cefee1e8)
30. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-7c1de3b5bdee4b50906e0217b04a3f48)
31. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-64ef49bdce7b46ac97148b18853d38ec)
32. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-9784d5e1fb524ab39821c261a59a5364)
33. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-a88c9b4598bb4230abce1161433e96ab)
34. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-a22652019972488c81774a784d90d7be)
35. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-7d6bd27ef6d249a0aa0d6275d5fc3430)
36. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-4a848363ec8047a98188a4e22390323c)
37. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-ae83f37b6348471eaa9a6e835e3ba9e0)
38. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-c648e0845f984486bfbb3a8b038cf8b3)
39. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=T-f9e7cc0d7583483fb0e95f4b7323b63e)
40. [cdn.pfizer.com](https://cdn.pfizer.com/pfizercom/Pfizer_Legacy_of_Manufacturing_Excellence_04042024.pdf)
41. [labeling.pfizer.com](https://labeling.pfizer.com/ShowLabeling.aspx?id=652)
42. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-b34fdae5806e4361a94abad7b64b1674)
43. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-ac83057bbe0e456ab1e556d16d6b12f5)
44. [PFIZER INC — Full financial report (2023 Y)](https://app.finbar.com/go?id=P-6aa7094537d04714b85e7be40264aafa)
45. [PFIZER INC — Full financial report (2013 Y)](https://app.finbar.com/go?id=P-55b41cf14a2745aeb03ea125fd78f107)
46. [PFIZER INC — Full financial report (2024 Y)](https://app.finbar.com/go?id=P-21ceb5df957948c4a1af4871c4dd520b)
47. [www.pfizer.com](https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-transaction-combine-its-upjohn-business)

AI-generated summary; may contain errors. Not investment advice. Sign up to Finbar to view original document sources and access worldwide fundamental financial data and intelligence.